Search
Umeclidini: tractament broncodilatador de manteniment per alleujar els símptomes de la malaltia pulmonar obstructiva crònica en pacients adults
(2017-04)
Umeclidini is a LAMA plus for the maintenance of COPD moderate to very serious. Its impact on the prevention of exacerbations is unknown and has not shown to be clinically superior to tiotropy in the improvement of pulmonary ...
Tafluprost/timolol en el tractament del glaucoma d’angle obert o la hipertensió ocular
(2019-03-14)
The goal of the treatment of glaucoma is to prevent significant loss of vision of the patient by reducing the IOP. Evidence has been shown to have shown that the reduction in IOP delayed progression, including GAO of normal ...
Lumacaftor/ivacaftor (Orkambi®) per al tractament de la fibrosi quística
(2019-10-15)
Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the gene that encodes the transmembrane conductance regulator of CF (CFTR), a protein that acts as a chloride channel. Viscous secretions ...
Furoat de fluticasona/bromur d'umeclidini/vilanterol per al tractament de manteniment de la malaltia pulmonar obstructiva crònica
(2019-04-01)
Furoat of fluticasone (FF) is a corticoid that increases the transcription of proteins
Anti-inflammatory, umeclidine bromide (UMEC) is a long-acting muscarinic antagonist (LAMA) that blocks the bronchoconstrictive action ...
Tractament del carcinoma de cèl·lules renals avançat en segona línia: informe d’avaluació de resultats
(2021)
The data reported by prescribers have been selected for patients who have been treated in the Integral Health System of Catalonia (SISCAT) with axitinib, cabozantinib (anti-VEGF), nivolumab (anti-PDL1) or everolimus (mTOR ...
Adalimumab: indicació avaluada; per al tractament de la uveïtis no infecciosa no anterior en pacients adults
(2017-09-04)
Uveitis is an inflammatory disease that affects the intermediate layer of the eye or uvea (iris, cosmylate and choroid), and that many times it can also affect adjacent structures. The illness attends symptoms of severe ...
Persones amb esclerosi múltiple: Catalunya 2013-2017 (33/2019)
(2019-05)
Multiple sclerosis (MS) is a chronic neurological disease that affects the central nervous system (CNS) through the immune system. It is the second cause of neurological disability in young adults, between 20 and 40 years. ...